General filters
Exact matches only
Search in title
Search in excerpt
Search in content
Source
Filter by Release categories
Accessible Tourism
Africa Tourism
Africa Travel
Agriculture
AI
Association News
Aviation
Awards
Business Travel
Climate
Conservation
Corporate
Culture
Ecotourism
Events
Female Travel
Food and Dining
Food and Drink
Hacks
Hospitality and Travel
Hotelier
Industry Insights
Insurance
Leadership
Leisure Travel and Tourism
Cruising
LGBTQ+
Lifestyle and Entertainment
Luxury Travel
MICE
Press releases
Responsible Tourism
South Africa
South Africa Travel
Sport
Sustainable Travel
Tax
Tech
Tips
Trade News
Travel and Tourism
Travel News
Travel Tips
Trends
Women

Five things to keep in mind when discussing vaccines and health passports

It’s been more than a year since the World Health Organization declared COVID-19 a global pandemic on 11 March 2020 – causing the travel industry to shut-down overnight.

And although green shoots are starting to appear in the form of domestic business travel, many travel managers do not expect demand for international travel to return to any significant levels until successful vaccine programmes are firmly in place.

But will vaccines spur the sector’s recovery in 2021 and beyond? 

“Here are just five things to keep in mind,” says Bonnie Smith, FCM General Manager South Africa when discussing vaccines and health passports:

  1. Vaccine programmes are moving at different speeds around the world

While the UK and US are meeting their vaccination targets (with President Biden setting an ambitious goal of returning the country to ‘near-normal’ by 04 July 2021), many other countries around the world are yet to gain momentum.

In the meantime, much of Europe is experiencing a third wave and countries in sub-Saharan Africa, like South Africa, are anticipating a third wave this winter (May/June). This means travel advisories and restrictions remain in place despite the progress around vaccination programmes.

  1. Different vaccines deliver different levels of protection against different strains

Much has been made of the new strains of COVID-19 emerging around the world. New strains have been detected in the UK, South Africa, Brazil, the US and Ghana (among others) and it raises a key concern: How do the available vaccines hold up against emerging variants?

Vaccine developers are working hard to establish the safety and efficacy of their vaccines against the new variants, and we can anticipate that work around vaccines (including the development of new, second-generation vaccines and boosters) will continue long into the future.

  1. Vaccinated or not, travellers will still need to be careful

It follows then, that vaccinated travellers will need to exercise as much caution as ever. Think masks, social distancing, and the liberal use of hand sanitiser.

COVID protocols will remain in firmly place and many innovations, like touchless tech, are likely to become an industry standard.

TMCs will still vet suppliers and partners in the travel industry (from accommodation establishments to transport providers) to ensure strict health and safety measures are adhered to. In other words, returning to ‘normal’ will still feel very different as we get back to travel. 

  1. A global approach to vaccinations will be required

This is perhaps the biggest challenge of all: How will different countries handle their travel policies, especially with regards to the vaccine? Will travellers require a health passport detailing their vaccination status? Will negative PCR tests still be required? These are just a few of the issues which need to be ironed out.

  1. What if travellers can’t or don’t want to be vaccinated?

A concern is that the roll-out of health passports for travel could potentially create a divide in the traveller demographics. What will happen to those travellers who might not have access to a vaccine or are not willing to be vaccinated? 

Travel groups around the world have indicated that although they believe vaccinated individuals should be exempt from international testing requirements, they do not support “vaccine requirements as a prerequisite for travel.”

Despite current challenges and questions, there is little doubt within the travel industry that the COVID-19 vaccine will have a massive – and positive – impact on the corporate travel landscape. China has already (as of end March 2021) vaccinated around 80 million citizens, while countries like Israel, the United Arab Emirates (UAE), and Bahrain lead the global effort to roll out vaccines. There’s definite progress, and it seems more and more likely that vaccinations will be at the heart of business travel’s recovery – and perhaps sooner than we think.

FCM is a member of the Good Health Pass Collaborative, an open, inclusive, cross-sector initiative, bringing together leading companies and organisations from the technology, health, and travel sectors. This collaborative is creating a blueprint for interoperable digital health pass systems and building a safe path to restore international travel and restart the global economy.

For more insights on business travel in a COVID-19 world, check out the latest FCM Whitepaper, which you can download here and here.

Upcoming Articles

Media Downloads

Share Article

Get daily news updates to your inbox!

Subscribe to receives daily updates!

Trending now

Proflight Zambia to co-host 55th AASA annual general assembly in Lusaka

One of the leading regional aviation conferences, the Airlines Association of Southern Africa (AASA)[...]

Conference Season Power Play: How to Make Every Event Count

JOHANNESBURG – Corporate travel budgets are surging across EMEA, with 46% of companies planning[...]

Garden Town Stellenbosch 2025 to Bloom Bigger Than Ever

One of South Africa’s most captivating garden lifestyle celebrations, Garden Town Stellenbosch, returns from[...]

WTM Africa to Host Key Africa Tourism Investment Conference (ATIC)

Cape Town – The Africa Tourism Investment Conference (ATIC), one of the continent’s leading[...]